These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1326304)

  • 1. Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells.
    Bertrand R; O'Connor PM; Kerrigan D; Pommier Y
    Eur J Cancer; 1992; 28A(4-5):743-8. PubMed ID: 1326304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
    Zeghari-Squalli N; Raymond E; Cvitkovic E; Goldwasser F
    Clin Cancer Res; 1999 May; 5(5):1189-96. PubMed ID: 10353756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants.
    Pavillard V; Kherfellah D; Richard S; Robert J; Montaudon D
    Br J Cancer; 2001 Sep; 85(7):1077-83. PubMed ID: 11592782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-phase population analysis does not correlate with the cytotoxicity of camptothecin and 10,11-methylenedioxycamptothecin in human colon carcinoma HT-29 cells.
    O'Connor PM; Nieves-Neira W; Kerrigan D; Bertrand R; Goldman J; Kohn KW; Pommier Y
    Cancer Commun; 1991 Aug; 3(8):233-40. PubMed ID: 1653585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro schedule dependency in the treatment of topoisomerase I and II inhibitor.
    Kimura T
    Osaka City Med J; 2001 Jun; 47(1):33-41. PubMed ID: 11556390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic cytotoxicity, apoptosis and protein-linked DNA breakage by etoposide and camptothecin in human U87 glioma cells: dependence on tyrosine phosphorylation.
    Ciesielski MJ; Fenstermaker RA
    J Neurooncol; 1999 Feb; 41(3):223-34. PubMed ID: 10359142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines.
    Mans DR; Grivicich I; Peters GJ; Schwartsmann G
    Eur J Cancer; 1999 Dec; 35(13):1851-61. PubMed ID: 10674003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe.
    Tse AN; Schwartz GK
    Cancer Res; 2004 Sep; 64(18):6635-44. PubMed ID: 15374978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: role of topoisomerase I.
    Sørensen BS; Jensen PB; Sehested M; Jensen PS; Kjeldsen E; Nielsen OF; Alsner J
    Biochem Pharmacol; 1994 Jun; 47(11):2105-10. PubMed ID: 8010996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topotecan increases topoisomerase IIalpha levels and sensitivity to treatment with etoposide in schedule-dependent process.
    Whitacre CM; Zborowska E; Gordon NH; Mackay W; Berger NA
    Cancer Res; 1997 Apr; 57(8):1425-8. PubMed ID: 9108439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell lines.
    Kouniavsky G; Khaikin M; Zvibel I; Zippel D; Brill S; Halpern Z; Papa M
    Clin Exp Metastasis; 2002; 19(1):55-60. PubMed ID: 11918083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems.
    Romanelli S; Perego P; Pratesi G; Carenini N; Tortoreto M; Zunino F
    Cancer Chemother Pharmacol; 1998; 41(5):385-90. PubMed ID: 9523734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells.
    O'Connor PM; Kerrigan D; Bertrand R; Kohn KW; Pommier Y
    Cancer Commun; 1990; 2(12):395-400. PubMed ID: 2176090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials.
    Tanizawa A; Fujimori A; Fujimori Y; Pommier Y
    J Natl Cancer Inst; 1994 Jun; 86(11):836-42. PubMed ID: 8182764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
    Houghton JA; Cheshire PJ; Hallman JD; Lutz L; Luo X; Li Y; Houghton PJ
    Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
    Kaufmann SH
    Cancer Res; 1991 Feb; 51(4):1129-36. PubMed ID: 1705167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule-dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitro.
    Aschele C; Baldo C; Sobrero AF; Debernardis D; Bornmann WG; Bertino JR
    Clin Cancer Res; 1998 May; 4(5):1323-30. PubMed ID: 9607593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence effect of irinotecan (CPT-11) and topoisomerase II inhibitors in vivo.
    Eder JP; Chan V; Wong J; Wong YW; Ara G; Northey D; Rizvi N; Teicher BA
    Cancer Chemother Pharmacol; 1998; 42(4):327-35. PubMed ID: 9744779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.
    Licitra EJ; Vyas V; Nelson K; Musanti R; Beers S; Thomas C; Poplin E; Smith S; Lin Y; Schaaf LJ; Aisner J; Gounder M; Rajendra R; Saleem A; Toppmeyer D; Rubin EH
    Clin Cancer Res; 2003 May; 9(5):1673-9. PubMed ID: 12738720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-dependent regulation of camptothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine.
    Sorensen M; Sehested M; Jensen PB
    Biochem Pharmacol; 1997 Aug; 54(3):373-80. PubMed ID: 9278096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.